Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glycerosaline, also known as glycerinated saline, is a pharmaceutical solution typically composed of a mixture of glycerin (glycerol) and physiological saline (sodium chloride in water). In the field of clinical dermatology and allergy research, it is primarily utilized as a negative control in diagnostic procedures such as the Human Repeat Insult Patch Test (HRIPT). Its role is to provide a baseline for non-irritancy, allowing investigators to distinguish between the skin's reaction to an experimental material—such as the SILURCLOUD Fibrous Collagen Matrix—and the reaction to the patching process or the vehicle itself. While glycerin is known for its emollient and humectant properties and saline is an isotonic electrolyte solution, the combination is considered pharmacologically inert in the context of skin sensitization testing. SerenaGroup, Inc. has employed glycerosaline as a comparator in clinical trials to evaluate the safety and biocompatibility of various wound care products and collagen-based matrices.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glycerosaline.